Rathbones Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-11,300
| Closed | -$91K | – | 439 |
|
|
2021
Q4 | $91K | Hold |
11,300
| – | – | ﹤0.01% | 410 |
|
|
2021
Q3 | $110K | Buy |
+11,300
| New | +$110K | ﹤0.01% | 406 |
|
|
2016
Q3 | – | Sell |
-14,056
| Closed | -$706K | – | 319 |
|
|
2016
Q2 | $706K | Sell |
14,056
-220
| -2% | -$11.1K | 0.04% | 170 |
|
|
2016
Q1 | $764K | Sell |
14,276
-1,270
| -8% | -$68K | 0.05% | 161 |
|
|
2015
Q4 | $983K | Sell |
15,546
-1,005
| -6% | -$63.5K | 0.06% | 138 |
|
|
2015
Q3 | $934K | Hold |
16,551
| – | – | 0.06% | 149 |
|
|
2015
Q2 | $978K | Sell |
16,551
-1,000
| -6% | -$59.1K | 0.06% | 149 |
|
|
2015
Q1 | $1.09M | Hold |
17,551
| – | – | 0.07% | 137 |
|
|
2014
Q4 | $1.01M | Buy |
17,551
+3,143
| +22% | +$181K | 0.07% | 150 |
|
|
2014
Q3 | $774K | Hold |
14,408
| – | – | 0.05% | 163 |
|
|
2014
Q2 | $755K | Buy |
+14,408
| New | +$755K | 0.05% | 164 |
|